A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) versus Placebo as Adjuvant Therapy in Participants with Hepatocellular Carcinoma and Complete Radiological Response after Surgical Resection or Local Ablation

  • Roberts, Stuart (Primary Chief Investigator (PCI))
  • Lewis, Paula (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date8/11/19 → 30/06/23

Keywords

  • Gastroenterology
  • Hepatocellular Carcinoma
  • Clinical trial

Clinical Trial Phase

  • Phase III (a & b)